Literature DB >> 21216627

Symptom disclosure by older HIV-infected persons.

Kathleen M Nokes1.   

Abstract

The life expectancy for persons living with HIV infection is markedly increasing, largely because of the advances made with antiretroviral therapy. In comparison with other older individuals, those infected with HIV tend to have higher rates of liver-related conditions, diabetes, and dyslipidemia, as well as substance use and psychiatric disorders. Although these multimorbidities contribute to the symptom burden, older persons with HIV tend not to disclose symptoms to their health care providers. Culture, religion, age, and race can profoundly affect the way in which symptoms are perceived, and reasons for nondisclosure include attributing symptoms to the "normal" aging process. The purpose of this article is to highlight the unique situation of older patients with HIV regarding symptom disclosure and the need for an integrated treatment plan that includes an environment that promotes patient-provider communication, better day-to-day self-care, and self-management strategies.
Copyright © 2011 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21216627     DOI: 10.1016/j.jana.2010.10.006

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  2 in total

1.  Faith-based HIV prevention and counseling programs: findings from the Cincinnati census of religious congregations.

Authors:  Magdalena Szaflarski; P Neal Ritchey; C Jeffrey Jacobson; Rhys H Williams; Amy Baumann Grau; Karthikeyan Meganathan; Christopher G Ellison; Joel Tsevat
Journal:  AIDS Behav       Date:  2013-06

2.  Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life.

Authors:  Alan T Rodriguez-Penney; Jennifer E Iudicello; Patricia K Riggs; Katie Doyle; Ronald J Ellis; Scott L Letendre; Igor Grant; Steven Paul Woods
Journal:  AIDS Patient Care STDS       Date:  2013-01       Impact factor: 5.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.